Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Iduronicrin genleukocel-T - Immusoft

Next Previous
X
Search
Drug Profile

Iduronicrin genleukocel-T - Immusoft

Alternative Names: ISP-001; Mucopolysaccharidosis type I therapy - Immusoft

Latest Information Update: 27 Sep 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Immusoft Corporation
  • Developer Immusoft
  • Class Cell therapies; Gene therapies
  • Mechanism of Action Cell replacements; Gene transference; Iduronidase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mucopolysaccharidosis I
  • New Molecular Entity No

Highest Development Phases

  • Phase I Mucopolysaccharidosis I

Most Recent Events

  • 23 Sep 2024 Efficacy, adverse events and pharmacodynamics data from a phase I trial in Mucopolysaccharidosis I released by Immusoft
  • 12 Apr 2023 Phase-I clinical trials in Mucopolysaccharidosis I (In adults, In the elderly) in USA (Parenteral) (NCT05682144)
  • 02 Sep 2022 US FDA approves IND application for Iduronicrin genleukocel-T (ISP-001) in Mucopolysaccharidosis type I (MPS I)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top